X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
monoamine oxidase (75) 75
index medicus (74) 74
humans (62) 62
monoamine oxidase - metabolism (60) 60
chemistry, medicinal (59) 59
monoamine oxidase inhibitors - pharmacology (59) 59
structure-activity relationship (55) 55
inhibition (46) 46
monoamine oxidase inhibitors - chemistry (46) 46
parkinsons-disease (39) 39
chemistry, organic (38) 38
animals (32) 32
monoamine oxidase inhibitors - chemical synthesis (32) 32
biochemistry & molecular biology (29) 29
mao (27) 27
parkinson's disease (27) 27
oxidases (26) 26
derivatives (25) 25
monoamine oxidase - chemistry (24) 24
analogs (23) 23
caffeine (22) 22
kinetics (22) 22
models, molecular (22) 22
molecular structure (21) 21
analysis (20) 20
dopamine (20) 20
reversible inhibition (20) 20
dose-response relationship, drug (19) 19
monoamine oxidase b (19) 19
reversible inhibitors (19) 19
pharmacology & pharmacy (18) 18
inhibitors (14) 14
inhibitory concentration 50 (14) 14
metabolism (13) 13
parkinson’s disease (13) 13
protein binding (13) 13
reversible (13) 13
mao-b (12) 12
receptor (12) 12
caffeine - analogs & derivatives (11) 11
drug design (11) 11
enzyme inhibitors (11) 11
nervous system diseases (11) 11
parkinson disease - drug therapy (11) 11
structure–activity relationship (11) 11
amine oxidase (10) 10
binding sites (10) 10
brain (10) 10
caffeine - pharmacology (10) 10
depression (10) 10
human-brain (10) 10
monoamine-oxidase-b (10) 10
recombinant proteins - metabolism (10) 10
alzheimer's disease (9) 9
competitive (9) 9
high-potency (9) 9
mice (9) 9
molecular docking (9) 9
neurodegenerative diseases (9) 9
papio (9) 9
selective-inhibition (9) 9
enzymes (8) 8
heterocyclic compounds (8) 8
levodopa (8) 8
male (8) 8
monoamine oxidase inhibitors - metabolism (8) 8
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (7) 7
catalytic domain (7) 7
chalcone (7) 7
design (7) 7
dual-target-directed drug (7) 7
molecular docking simulation (7) 7
movement disorders (7) 7
oxidase (7) 7
rats (7) 7
serotonin toxicity (7) 7
b inhibitors (6) 6
brain - metabolism (6) 6
dialysis (6) 6
disease (6) 6
l-dopa (6) 6
methylene blue (6) 6
mice, inbred c57bl (6) 6
monoamine oxidase - drug effects (6) 6
neuroprotective agents - pharmacology (6) 6
resolution (6) 6
adenosine a (5) 5
adenosine a2 receptor antagonists (5) 5
antagonism (5) 5
antidepressants (5) 5
chalcones (5) 5
chemistry, multidisciplinary (5) 5
chromone (5) 5
crystallography, x-ray (5) 5
dopaminergic neurotoxicity (5) 5
drugs (5) 5
in-vitro (5) 5
medical treatment (5) 5
methylene-blue (5) 5
nitric oxide (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Planta Medica, ISSN 0032-0943, 10/2019, Volume 85, Issue 14/15, pp. 1136 - 1142
Abstract Monoamine oxidases (MAOs) are key metabolic enzymes for neurotransmitter and dietary amines and are targets for the treatment of neuropsychiatric and... 
Biological and Pharmacological Activity | SITE | kavain | CHEMISTRY, MEDICINAL | ENRICHED EXTRACT | MITOCHONDRIAL | Piperaceae | HIGH-POTENCY | inhibition | CARDIAC DYSFUNCTION | Piper methysticum | PLANT SCIENCES | kava | INTEGRATIVE & COMPLEMENTARY MEDICINE | PHARMACOLOGY & PHARMACY | yangonin | BINDING | monoamine oxidase | PARKINSONS-DISEASE
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 11/2019, Volume 29, Issue 21, p. 126677
The present study investigates the monoamine oxidase (MAO) inhibition properties of a series of ten 5-aryl-1,3,4-oxadiazol-2-ylbenzenesulfonamides. The target... 
Oxadiazole | MAO | Monoamine oxidase | Sulfonamide | Inhibition | Zonisamide | CHEMISTRY, MEDICINAL | CHEMISTRY, ORGANIC | REVERSIBLE INHIBITORS | DERIVATIVES
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 01/2019, Volume 29, Issue 1, pp. 40 - 46
Series of structurally diverse 2-imidazoline derivatives have been synthesized by condensation of substituted aldehydes with ethylenediamine, Pd-catalyzed... 
MAO | Monoamine oxidase | Inhibition | Selective | 2-Imidazoline | TARGET | DESIGN | CHEMISTRY, MEDICINAL | CHEMISTRY, ORGANIC | REVERSIBLE INHIBITORS | BINDING | Oxidases | Usage | Nervous system diseases | Prostate cancer | Ethylenediamines
Journal Article
Molecular Diversity, ISSN 1381-1991, 11/2019, Volume 23, Issue 4, pp. 897 - 913
Based on reports that chromone compounds are good potency inhibitors of monoamine oxidase (MAO), the present study evaluates the effect of substitution with... 
Life Sciences | Biochemistry, general | Polymer Sciences | Competitive | Chromandione | Monoamine oxidase | Chromone | Pharmacy | MAO | Inhibitor | Parkinson’s disease | Organic Chemistry
Journal Article
Central Nervous System Agents in Medicinal Chemistry, ISSN 1871-5249, 08/2019, Volume 19, Issue 2, p. 133
Background: The most effective symptomatic treatment of Parkinson’s disease remains the metabolic precursor of dopamine, L-dopa. To enhance the efficacy of... 
Parkinson's disease | Methyltransferase | Oxidase | Catechol O-methyltransferase | Alizarin | Levodopa | Inhibition | Movement disorders | Recombinant | Dihydroxyphenylalanine | Enzymes | Catechin | Dopamine | Neurodegenerative diseases | Medical treatment | Chlorogenic acid | Catechol | Metabolism | Rutin | Disease control | Amine oxidase (flavin-containing) | Inhibitors | Natural products | Dialysis | Dopa
Journal Article
Journal Article
Drug Development Research, ISSN 0272-4391, 11/2019, Volume 80, Issue 7, pp. 970 - 980
In recent studies, we have investigated the monoamine oxidase (MAO) inhibition properties of pyrrolo[3,4‐f]indole‐5,7‐dione and indole‐5,6‐dicarbonitrile... 
inhibition | MAO | N‐oxide | pyrrolo[3,4‐f]indole‐5,7‐dione, indole‐5,6‐dicarbonitrile | monoamine oxidase | Oxidases | Nervous system diseases | Lead compounds | Resveratrol
Journal Article
Central nervous system agents in medicinal chemistry, ISSN 1871-5249, 2018, Volume 18, Issue 2, pp. 115 - 127
Journal Article
Bioorganic Chemistry, ISSN 0045-2068, 04/2019, Volume 85, pp. 60 - 65
Parkinson’s disease is characterised by the death of the nigrostriatal neurons and depletion of striatal dopamine. The standard symptomatic therapy consists of... 
MAO | Monoamine oxidase | Quinazolinone | Inhibition | Parkinson’s disease | Parkinson's disease | LOCALIZATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, ORGANIC | CNS | CARBIDOPA | LEVODOPA | IN-VITRO | PARKINSONS-DISEASE | Enzymes | Analysis
Journal Article
Journal Article
Central Nervous System Agents in Medicinal Chemistry, ISSN 1871-5249, 08/2016, Volume 16, Issue 2, pp. 112 - 119
A screening study aimed at identifying inhibitors of the enzyme, monoamine oxidase (MAO), among clinically used drugs have indicated that the antirheumatic... 
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 05/2014, Volume 66, Issue 5, pp. 677 - 687
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 12/2016, Volume 26, Issue 24, pp. 5951 - 5955
Based on a previous report that a series of 8-(phenoxymethyl)-xanthines may be promising leads for the design of A adenosine receptor antagonists, selected... 
Adenosine A1 and A2A receptor antagonists | 1,3-Diethyl-7-methyl-8-(phenoxymethyl)-xanthines | 1,3,7-Trimethyl-8-(phenoxymethyl)-xanthines | Caffeine
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 12/2016, Volume 26, Issue 24, p. 5951
Display Omitted 
Xanthine
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.